Nodular fasciitis (NF) is a relatively common mass-forming and self-limited subcutaneous pseudosarcomatous myofibroblastic proliferation of unknown pathogenesis. Due to its rapid growth and high mitotic activity, NF is often misdiagnosed as a sarcoma. While studying the USP6 biology in aneurysmal bone cyst and other mesenchymal tumors, we identified high expression levels of USP6 mRNA in two examples of NF. This finding led us to further examine the mechanisms underlying USP6 overexpression in these lesions. Upon subsequent investigation, genomic rearrangements of the USP6 locus were found in 92% (44 of 48) of NF. Rapid amplification of 5 0 -cDNA ends identified MYH9 as the translocation partner. RT-PCR and direct sequencing revealed the fusion of the MYH9 promoter region to the entire coding region of USP6. Control tumors and tissues were negative for this fusion. Xenografts of cells overexpressing USP6 in nude mice exhibited clinical and histological features similar to human NF. The identification of a sensitive and specific abnormality in NF holds the potential to be used diagnostically. Considering the self-limited nature of the lesion, NF may represent a model of 'transient neoplasia', as it is, to our knowledge, the first example of a self-limited human disease characterized by a recurrent somatic gene fusion event.
Nodular fasciitis (NF) is a relatively common mass-forming and self-limited subcutaneous pseudosarcomatous myofibroblastic proliferation of unknown pathogenesis. Due to its rapid growth and high mitotic activity, NF is often misdiagnosed as a sarcoma. While studying the USP6 biology in aneurysmal bone cyst and other mesenchymal tumors, we identified high expression levels of USP6 mRNA in two examples of NF. This finding led us to further examine the mechanisms underlying USP6 overexpression in these lesions. Upon subsequent investigation, genomic rearrangements of the USP6 locus were found in 92% (44 of 48) of NF. Rapid amplification of 5 0 -cDNA ends identified MYH9 as the translocation partner. RT-PCR and direct sequencing revealed the fusion of the MYH9 promoter region to the entire coding region of USP6. Control tumors and tissues were negative for this fusion. Xenografts of cells overexpressing USP6 in nude mice exhibited clinical and histological features similar to human NF. The identification of a sensitive and specific abnormality in NF holds the potential to be used diagnostically. Considering the self-limited nature of the lesion, NF may represent a model of 'transient neoplasia', as it is, to our knowledge, the first example of a self-limited human disease characterized by a recurrent somatic gene fusion event. Nodular fasciitis (NF) is a mesenchymal lesion that commonly occurs in the upper extremities, trunk, head and neck of children and young adults. 1, 2 The most common clinical presentation is a 2-3-week history of a rapidly growing subcutaneous mass, which is concerning for a possible malignant neoplasm. [1] [2] [3] However, NF regresses spontaneously when not surgically resected; thus, it has been clinically viewed as a peculiar reactive process.
1,2 Histologically, NF closely simulates sarcomas because of its high cellularity and high mitotic activity. [1] [2] [3] This deceptive histological appearance may result in erroneous diagnoses and inadequate treatment. [4] [5] [6] Since its initial description by Konwaler et al, 7 the neoplastic nature of NF has been debated. [8] [9] [10] [11] Although a few studies showed evidence that at least a subset of NF were clonal in nature, others were unable to confirm these findings. [8] [9] [10] [11] In a few reports where cytogenetical analysis was possible, no specific or consistent recurrent abnormality has been found. [8] [9] [10] [11] We recently identified the USP6 locus as a recurrent target in aneurysmal bone cyst (ABC), a bone tumor that predominantly occurs in the pediatric population. [12] [13] [14] [15] [16] [17] This prompted us to study the biology and possible oncogenic role of USP6 in other mesenchymal entities. Herein, we report that USP6 rearrangements with the formation of the fusion gene MYH9-USP6 occur in most examples of NF. Our finding not only confirms the clonal neoplastic nature of NF, but also suggests a novel model of 'transient neoplasia', as it is, to our knowledge, the first example of a self-limited human lesion characterized by a recurrent somatic gene fusion event.
MATERIALS AND METHODS Primary Tumors and Controls
Institutional Review Board permission was obtained for this study. Forty-eight cases of NF were identified at Mayo Clinic, Rochester. All cases showed classic histological features: a subcutaneous cellular spindle cell proliferation exhibiting prominent mitotic activity, occasional microcystic changes and extravasated erythrocytes and inflammatory cells. 1, 2 Negative controls included four dermatofibrosarcoma protuberans, four myofibromas, three schwannomas, three desmoid-type fibromatoses, three myxofibrosarcomas, three proliferative fasciitis, two proliferative myositis, two neurofibromas, two osteosarcomas, two benign fibrous histiocytomas, two adenocarcinomas, two desmoplastic fibroblastomas, and one each of visceral fasciitis, ischemic fasciitis, giant cell tumor of soft tissues, normal fibroadipose tissue, high-grade undifferentiated pleomorphic sarcoma, leiomyoma, intramuscular myxoma, soft tissue perineurioma, papillary thyroid carcinoma, non-ossifying fibromyxoid tumor of soft parts and capillary hemangioma (n ¼ 43). Five ABCs with confirmed USP6 fusion genes were used as positive controls.
Nucleic Acid Extraction
Frozen tissue was available from two examples of NF. An additional 46 cases of NF were obtained from paraffin blocks or available unstained slides. RNA from frozen samples was mechanically homogenized using Trizol (Invitrogen, Carlsbad, CA) and extracted according to established methods. 18 RNA from formalin-fixed paraffin-embedded (FFPE) samples was extracted using 10-mm sections and by using established methods. 18 qRT-PCR for USP6 To confirm expression of USP6 mRNA in NF, qRT-PCR was performed using the LightCycler5 480 Probes Master kit per manufacturer's instruction (Roche, Mannheim, Germany). Quantification was based on the relative expression of target gene (USP6) versus a reference gene (PGK). All samples were normalized against uterus mRNA. Using Roche's universal primer library (UPL), primers for USP6 (5 0 -CCCCCATT ATGATTTTTGAACGG-3 0 , 5 0 -TTGTTGTGAACCTCTCCGC AG-3 0 ) and UPL probe 62 (5 0 -ACCTGCTG-3 0 ), along with primers for PGK (5 0 -GGAGAACCTCCGCTTTCAT-3 0 , 5 0 -GC TGGCTCGGCTTTAACC-3 0 ) and UPL probe 69 (5 0 -GGAGG AAG-3 0 ), were subjected to qRT-PCR using the two index cases of NF, along with two other NFs, two Ewing sarcomas, one synovial sarcoma and three normal tissues (ovary, uterus and myometrium). Testis mRNA was used as a positive control, as USP6 is primarily expressed in this tissue. Cycling conditions were 94 1C for 10 min, followed by 40 cycles of 94 1C for10 s, 58 1C for 40 s and 72 1C for 10 s. 0 end of MYH9 in spectrum orange and the 3 0 end of USP6 in spectrum green. DNA isolation, nick translation and hybridization were performed as described previously. 19 Tissues were scored by two independent investigators and considered positive if Z10% of 200 cells showed split signals. FISH images were captured using a Leica DM 6000 scope (Leica, Bannockbun, IL) with Cytovision software (Genetix, Boston, MA).
5
0 -RACE PCR RACE-ready cDNA was generated using 1 mg of RNA from NF1 and NF2, using SMARTer RACE cDNA Amplification kit (Clonetech, Mountain View, CA) per manufacturer's instructions. 
. Products were visualized on 3% gels and photographed using a DigiDoc-It imager (UVP, Upland, CA). DNA was extracted using Qiaquick gel extraction columns (Qiagen, Valencia, CA) per manufacturer instructions.
RT-PCR for MYH9-USP6
RT-PCR for MYH9-USP6 fusion was performed on FFPE RNA. One microgram RNA was reverse transcribed using iScript Select cDNA Synthesis Kit (BioRad, Hercules, CA), using random primers per manufacturer instruction. PCR was performed using USP6 primers (5 
Sequencing
Products were sequenced at the Mayo Clinic Sequencing Core, using the Applied Biosystems' BigDye XTerminator v1.1. kit chemistry for cycle sequencing and processed on a pair of ABI 3730/3730 Â l DNA Analyzer capillary electrophoresis instruments (ABI, Foster City, CA).
Xenograft and Histological Analysis MC3T3-E1 is a murine preosteoblastic cell line obtained from ATCC. USP6 expression was placed under the control of a doxycycline (dox)-inducible promoter in MC3T3-E1 cells. USP6-transfected MC3T3-E1 cells (2.5E6 in 250 ml) were injected subcutaneously into the rear flank. Nude male mice (4-8 weeks) were obtained from Jackson Laboratories and fed water containing 1 mg/ml dox (Research Products International, Mt Prospect, IL) supplemented with 5% sucrose for 1-2 weeks prior to xenografting. Following induction of the xenograft, dox was maintained in the drinking water and animals were monitored every 1-2 days for a period of 2-4 weeks. 20 All mouse procedures were conducted in accordance with guidelines set by IACUC at the University of Pennsylvania and Children's Hospital of Philadelphia. Tumors were paraffin-embedded, and histological analysis was performed by the Abramson Cancer Center Pathology Core of the University of Pennsylvania and Mayo Clinic. Histological sections (4 mm) were prepared and subjected to hematoxylin and eosin staining.
RESULTS

Clinical Findings
Clinical and molecular characteristics of NF (n ¼ 48) are summarized in Table 1 . Average age of NF patients was 33 years (range 4-70 years) with a 1:1.5 male to female ratio. Average lesion size was 1.8 cm (range: 0.7-4.8 cm), and the most common site of occurrence was the forearm (n ¼ 10) (Table 1) .
USP6 mRNA Expression Profiling
Screening of primary mesenchymal tumors and cell lines for USP6 transcriptional upregulation revealed unusually high levels of USP6 mRNA in NF, when compared with other tumors and normal tissues (Figure 1a) . These unexpected findings led us to further explore possible mechanisms responsible for USP6 mRNA transcriptional upregulation.
FISH for USP6, CDH11 and COL1A1
After excluding gene amplification by FISH and activating point mutations by direct sequencing (data not shown), we identified balanced rearrangement of USP6 locus in 44 of 48 Figure 1b) . Considering that the pathogenesis of ABC is mediated by USP6 oncogenic fusions with several partner genes with highly active promoters, most commonly CDH11 and COL1A1, [12] [13] [14] [15] [16] [17] we first excluded the involvement of these genes in NF by FISH and RT-PCR. No rearrangement of CDH11 or COL1A1 loci was found (data not shown).
5
0 -RACE PCR and Sequencing 5 0 RACE on two examples of NF was then performed to identify a possible novel USP6 fusion partner ( Figure 1c) ; the fusion of MYH9 exon 1 to USP6 exons 1 and 2 was identified in both instances (Figure 2a ).
RT-PCR and Sequencing
Specific RT-PCR confirmed the MYH9-USP6 fusion; two splice variants recognized: MYH9 non-coding exon 1 fused to USP6 exon 1 (Type I 5 0 -GGGGCAGATCCAGGTTCAG-3 0 -5 0 -GAAACTGGGCATCTCTGTGGC-3 0 ; Genbank Accession no. 1385057) and MYH9 non-coding exon 1 fused with USP6 exon 2 (Type II 5 0 -GGGGCAGATCCAGGTTCAG-3 0 -5 0 -GAT GGACATGGTAGAGAATGC-3 0 ; Genbank Accession no. 
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. The MYH9-USP6 fusion was found in 12 of 16 (75%) NF cases in which material was available; MYH9-USP6 fusion transcripts were negative in all 43 controls tested (Figure 2b) . Four examples of NF co-expressed the two fusion transcripts variants and the remaining eight expressed only the type I fusion (Table 1) . No reciprocal fusion gene (USP6-MYH9) was identified.
FISH for MYH9
A balanced rearrangement of MYH9 was found in 31/48 cases (65%) (Table 1, Figure 3a) . To further confirm the fusion of MYH9 to USP6, a dual FISH approach was taken and showed that the MYH9 locus was juxtaposed to the USP6 locus in all instances (Figure 3b ). MYH9 was only rearranged when USP6 was also rearranged; MYH9 was not rearranged in any of the 43 control tumors or other tissues tested (data not shown). Four examples of NF were negative for rearrangements of both USP6 and MYH9 loci (Table 1) .
Xenograft Histological Analysis
We further sought to determine whether USP6 overexpression was sufficient to elicit the formation of tumors that recapitulate human NF. USP6 expression was placed under the control of a dox-inducible promoter MC3T3-E1 cells, and these cells were then injected subcutaneously in a similar location where NF often occurs. Xenografts yielded tumors clinically and histologically identical to human NF (Figures 3c, d, respectively) . The lesions were characterized by a rapid proliferation of spindle cells associated with areas of hemorrhage and prominent mitotic activity (3-10/high power fields). They become visible in 5-7 days, reached a maximum size (3-10 mm) within 2-3 weeks and then regressed (Figure 3c) , mimicking closely the clinico-pathological features of human NF (Figure 3d ).
DISCUSSION
NF is a self-limited, mass-forming subcutaneous myofibroblastic proliferation of unknown etiology that predominantly affects younger individuals.
1,2 Interestingly, NF shows a peculiar clinical behavior characterized by spontaneous regression after a few weeks when not surgically excised; this peculiar clinical presentation has led to the historical view that NF is a reactive process of uncertain etiology.
1,2 Only rare examples of NF have been characterized at the cytogenetic level, and no recurrent or consistent abnormality has been observed. [8] [9] [10] [11] We first identified two cases of NF that expressed unexpected high levels of USP6 mRNA. Subsequent studies showed 92% of NF contained rearrangements of the USP6 locus and 65% of those formed the novel fusion MYH9-USP6 (Table 1) .
USP6 belongs to a large subfamily of de-ubiquitinating enzymes that act in diverse cellular processes such as intracellular trafficking, protein turnover, inflammatory signaling and cell transformation. 12, 13 USP6 is located on chromosome 17p13 and has very limited expression in normal cells (with predominant expression in testes).
12,13 USP6 was first identified as a possible oncogene when it exhibited transforming properties upon overexpression in NIH-3T3 cells. 12, 13 Subsequently, our group identified USP6 oncogenes in ABC, a locally recurrent mesenchymal neoplasm more commonly found in younger patients. [12] [13] [14] [15] [16] [17] More recently, we reported the USP6-induced expression of matrix metalloproteases through activation of NF-kB, a transcription factor with a key role in inflammation and proliferation.
16
MYH9 is located on chromosome 22q12.3-q13 and is a member of the non-muscle myosin class II family. [21] [22] [23] [24] [25] [26] MYH9 encodes for a protein involved in cytokinesis, cell motility, maintenance of cell shape, and more recently, found to have a direct role in actin network disassembly of crawling cells. [21] [22] [23] [24] [25] [26] MYH9 is found at relatively low levels in the body, except in fibroblasts, endothelial cells, macrophages, leukocytes and certain renal cells. [21] [22] [23] [24] [25] [26] MYH9 germline mutations have been reported in a number of human platelet disorders, and in 2003, Lamant et al 24 reported MYH9 fused to ALK in an anaplastic large cell lymphoma. Another family member, MYH11, is fused to CBFB in acute myelogenous leukemia with eosinophilia. 25 As previously mentioned, only a few NF has been characterized by standard cytogenetical analysis, but no specific abnormality has been found, except for an increased occurrence of chromosome 15 rearrangements. [8] [9] [10] [11] This observation can be explained by the fact that both MYH9 and USP6 are located in light-stained terminal bands (22q12.3-q13 and 17p13, respectively), making the detection of this rearrangement quite challenging, using traditional cytogenetical analysis. 27 A similar situation can be exemplified with ETV6 (TEL)-NTRK3 fusion in infantile fibrosarcoma, which went undetected for years using traditional cytogenetical analysis, because both genes are located at the end of chromosomes 12 and 15, respectively. 28, 29 Interestingly, ABC and NF have overlapping histological features that have not been previously emphasized. Both are characterized by a proliferation of bland spindle cells intermixed with inflammatory cells. 1, 2, 30 Although hemorrhagic cysts are typical of ABC, extravasated erythrocytes and microcystic formation are typically present in NF. 1, 2, 30 These similarities suggest that these histological manifestations may have a common pathogenic denominator mediated by USP6 transcriptional upregulation.
Our findings also suggest that, although USP6 transcriptional upregulation may be the driving force behind the high proliferative activity and growth of NF, the consistent involutional nature of the lesion indicates that additional genetical or stromal factors are required for maintaining its long-term survival and viability. Moreover, NF appears to be the first example of a self-limited, tumor-like lesion, characterized by a recurrent, somatic gene fusion event. This finding challenges the traditional concept that acquired nonrandom fusion gene abnormalities are the sole domain of sustained, autonomous neoplastic proliferations. In this regard, the hematopoietic system is most informative for comparative purposes. Although several examples of aberrant lymphoma-associated gene fusion events are described in B-lymphocyte populations with increasing age, these occurrences are incidental and do not manifest as self-limited, tumor-like expansions. 31 Future studies are necessary to better understand the mechanism by which the oncogenic activation of USP6 generates the unique clinical behavior of NF.
Furthermore, the identification of a sensitive and specific abnormality in NF also holds the potential to be used diagnostically.
In conclusion, our study uncovers the etiology of an entity whose pathogenesis has otherwise long remained a mystery. The mechanism seems to involve USP6 transcriptional upregulation due to its fusion with a strong ectopic promoter (MYH9). The identification of a sensitive and specific abnormality in NF holds the potential to provide a novel diagnostic avenue for these lesions. More importantly, NF seems to be the first example of a self-limited human lesion, characterized by a recurrent somatic gene fusion event.
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